Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder
Open Access
- 1 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 134 (6), 862-872
- https://doi.org/10.1309/ajcpacnudwen9gn4
Abstract
We examined diagnostic variation of flat intraurothelial lesions with comparison with immunohistochemical and fluorescence in situ hybridization (FISH) analyses. Nine uropathologists diagnosed 23 biopsy samples from the urinary bladder. The samples were analyzed by immunohistochemical expression of cytokeratin 20, high-molecular-weight cytokeratin, Ki-67, p53, and p16INK4a, and multicolor FISH using the UroVysion probe set (Vysis, Abbott, Des Plaines, IL). Diagnostic agreement for each classification and for nonneoplastic or neoplastic lesions was obtained in 8 (35%) and 16 (70%) of 23 lesions, respectively. The preference ratio of neoplasia to nonneoplasia (0.9 to 4.8) or carcinoma in situ to dysplasia (0.2 to 4.0) also varied among the pathologists. In 6 ancillary analyses, the majority of neoplastic lesions with diagnostic agreement indicated more than 2 aberrant results, whereas the majority of lesions without diagnostic agreement showed no or only 1 aberrant result. The molecular and immunohistochemical analyses can discriminate between neoplastic and nonneoplastic lesions; however, they cannot reliably solve diagnostic variation of flat intraepithelial lesions.Keywords
This publication has 24 references indexed in Scilit:
- p16INK4a Expression Analysis as an Ancillary Tool for Cytologic Diagnosis of Urothelial CarcinomaAmerican Journal of Clinical Pathology, 2009
- Bladder Cancer Detection Using FISH (UroVysion Assay)Advances in Anatomic Pathology, 2008
- Prospective Evaluation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the BladderJournal of Urology, 2008
- Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytologyCancer, 2007
- Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesionsJournal of Clinical Pathology, 2007
- Conservation and Alteration of Chromosome Territory Arrangements in Thyroid Carcinoma Cell NucleiThyroid®, 2007
- Expression of cytokeratin 20 in urine cytology smears: a potential marker for the detection of urothelial carcinomaCytopathology, 2007
- High-molecular-weight cytokeratin antibody (clone 34betaE12) as a urothelial marker: a note of cautionHistopathology, 2004
- Immunohistochemical Expression of CK20, p53, and Ki-67 as Objective Markers of Urothelial DysplasiaLaboratory Investigation, 2003
- Multiprobe FISH for Enhanced Detection of Bladder Cancer in Voided Urine Specimens and Bladder WashingsAmerican Journal of Clinical Pathology, 2001